Dr. Harsimran: The Rising Star of Punjab in Interventional Cardiology

Dr. Harsimran: The Rising Star of Punjab in Interventional Cardiology

 

PATIALA, Dr. Harsimran Jit Singh, Senior Consultant in Cardiology at Park Hospital, Patiala, has been instrumental in advancing cardiac care in the region. Under his leadership, the hospital has achieved significant milestones, including the successful completion of over 3,000 cardiac interventions.

The facility offers a comprehensive range of advanced cardiac procedures such as primary and complex angioplasties, biventricular pacemaker (CRT) implantations, implantable cardioverter-defibrillators (ICDs), carotid artery stenting, and Transcatheter Aortic Valve Replacement (TAVR/TAVI) .

Dr. Harsimran Jit Singh’s role in establishing Park Hospital, Patiala, as a center of excellence for cardiac sciences suggests his significant involvement in pioneering such advanced procedures in the region.

Dr. Harsimran has rapidly emerged as a dynamic and skilled interventional cardiologist in Punjab, earning recognition for his expertise in advanced procedures like TAVR, complex PCI, and structural heart interventions. With a commitment to excellence and patient-centered care, he is not only transforming cardiac outcomes in the region but also serving as a role model for the next generation of physicians.

Whether it’s pioneering new techniques, mentoring young cardiologists, or participating in cutting-edge conferences, Dr. Harsimran exemplifies the perfect blend of clinical acumen, innovation, and leadership. His consistent performance, growing patient trust, and collaboration with national KOLs signal a promising future—not just for him, but for Punjab’s healthcare landscape.

Dr Singh did first Ever Aortic Valve implant (TAVR) in Patiala making the region self-sufficient in critical care.

TAVR (Transcatheter Aortic Valve Replacement) is a minimally invasive procedure used to replace a diseased aortic valve, typically in patients with severe aortic stenosis who are at intermediate or high surgical risk.


May 2 2025 1:06PM
Source: